Emmessar Biotech & Nutrition Limited (BOM:524768)
India flag India · Delayed Price · Currency is INR
25.99
-0.21 (-0.80%)
At close: May 26, 2026

BOM:524768 Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
4.363.167.55.044.75
Depreciation & Amortization
10.980.980.940.92
Other Operating Activities
-1.611.55-4.392.78-0.54
Change in Accounts Receivable
0.010.05-0.120.0226.97
Change in Inventory
0.27-0.350.47-0.68-0.01
Change in Accounts Payable
0.03-0.060.09-0.22-4.75
Change in Other Net Operating Assets
-1.4-3.091.92-4.11-4.65
Operating Cash Flow
2.652.246.453.7622.7
Operating Cash Flow Growth
18.45%-65.28%71.34%-83.43%385.13%
Capital Expenditures
-0.09---0.26-3.06
Investment in Securities
-6.05-6.92-9.9-7.79-24.58
Other Investing Activities
3.574.633.472.591.49
Investing Cash Flow
-2.57-2.3-6.44-5.46-26.14
Other Financing Activities
0.140.04---
Financing Cash Flow
0.140.04---
Miscellaneous Cash Flow Adjustments
0----
Net Cash Flow
0.23-0.030.01-1.7-3.45
Free Cash Flow
2.572.246.453.519.64
Free Cash Flow Growth
14.66%-65.28%84.22%-82.19%321.44%
Free Cash Flow Margin
10.66%10.48%31.57%13.91%110.78%
Free Cash Flow Per Share
0.480.451.290.703.93
Cash Interest Paid
-0.01---
Cash Income Tax Paid
-0.17-0.2-0.62-2.92
Levered Free Cash Flow
-4.914.864.50.6816.64
Unlevered Free Cash Flow
-4.8814.874.50.6816.64
Change in Working Capital
-1.1-3.452.36-4.9917.57
Source: S&P Global Market Intelligence. Standard template. Financial Sources.